Global Medical Cures™ | Gastroesphageal Reflux in Infants

Global Medical Cures™ | Gastroesphageal Reflux in Infants

• 1.
  Gastroesophageal Reflux inInfants National Digestive Diseases Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH U.S. Department of Health and Human Services What is gastroesophageal reflux (GER)? Gastroesophageal reflux (GER) occurs when stomach contents reflux, or back up, into the esophagus during or after a meal. The esophagus is the tube that connects the mouth to the stomach. A ring of muscle at the bottom of the esophagus opens and closes to allow food to enter the stomach. This ring of muscle is called the lower esophageal sphincter (LES). The LES normally opens to release gas after meals. With infants, when the LES opens, stomach contents often reflux into the esophagus and out the mouth, resulting in regurgita­ tion, or spitting up, and vomiting. GER can also occur when babies cough, cry, or strain. What are the symptoms of GER? GER is common in healthy infants. More than half of all babies experience reflux in the first 3 months of life, but most stop spitting up between the ages of 12 to 24 months. Only a small number of infants have severe symptoms. An infant with GER may experience • spitting up • vomiting • coughing • irritability • poor feeding • blood in the stools In a small number of babies, GER results in symptoms that cause concern. These symptoms include • poor growth due to an inability to hold down enough food • irritability or refusing to feed due to pain • blood loss from acid burning the esophagus • breathing problems These problems can be caused by disorders other than GER. Your health care provider will need to determine whether GER is the cause of your child’s symptoms. Digestive system noting the mouth, esophagus, lower esophageal sphincter (LES), stomach, and small intestine.
• 2.
  How is GERdiagnosed? An infant who is consistently spitting up or vomiting may have GER. The doctor or nurse will talk with you about your child’s symptoms and examine your child. Tests may be ordered to help determine whether your child’s symptoms are related to GER. Sometimes treatment is started without tests. If the infant is healthy, content, and growing well, often no tests or treatment are needed. What is the treatment for GER? The treatment for reflux depends on an infant’s symptoms and age. Some babies may not need treatment because GER often resolves by itself. Healthy babies may only need their feedings thickened with cereal and to be kept upright after eating. Overfeeding can aggravate reflux, so your health care provider may suggest different ways of handling feedings. For example, smaller quantities with more frequent feedings can help decrease the chances of Call your child’s health care provider right away if any of the following occur: • vomiting large amounts or persistent projectile (forceful) vomiting, particularly in infants younger than 2 months old • vomiting fluid that is green or yellow or that looks like coffee grounds or blood • difficulty breathing after vomiting or spitting up • refusing food that seems to result in weight loss or poor weight gain • excessive crying and irritability regurgitation. If a food allergy is suspected, you may be asked to change the baby’s formula. Breastfeeding mothers may be asked to change their own diets for 1 to 2 weeks. If a child is not growing properly, higher-calorie food or tube feeding may be recommended. When an infant is uncomfortable, has diffi­ culty sleeping or eating, or does not grow, your health care provider may suggest a trial of medication to decrease the amount of acid in the stomach. Any potential com­ plications related to the medication will be explained. However, most infants don’t need medication and outgrow reflux by 1 or 2 years of age. *If medication is needed, treatment will often start with a class of medications called H2-blockers, also called H2-receptor agonists. These drugs help keep acid from backing up into the esophagus. H2-block­ ers are often used to treat children with GER because they come in liquid form. H2-blockers include • cimetidine (Tagamet) • ranitidine (Zantac) • famotidine (Pepcid) • nizatidine (Axid) A second class of medications often used to reduce stomach acid is proton-pump inhibitors (PPIs), which block the produc­ tion of stomach acid. PPIs include • esomeprazole (Nexium) • omeprazole (Prilosec) • lansoprazole (Prevacid) • rabeprazole (Aciphex) • pantoprazole (Protonix) * The authors of this fact sheet do not specifically endorse the use of drugs for children that have not been tested in children (“off label” use). Such a determination can only be made under the recommendation of the treating health care provider. 2 Gastroesophageal Reflux in Infants
• 3.
  Specific Instructions forInfants with GER • If you feed your baby with a bottle, add up to 1 tablespoon of rice cereal to 2 ounces of infant milk. You can add cereal to expressed milk if you are breastfeeding. If the mixture is too thick for your baby you can change the nipple size or cut a little “x” in the nipple. • Burp your baby after he’s consumed 1 or 2 ounces of formula. For breast-fed infants, burp after feeding on each side. • Do not overfeed. Talk with your infant’s doctor or nurse about the amount of formula or breast milk that your baby is consuming. • When possible, hold your infant upright in your arms for 30 minutes after feedings. • Infants with GER should usually sleep on their backs, as is suggested for all infants. Rarely, a physician may sug­ gest alternative sleep positions. Points to Remember • GER occurs when stomach contents back up into the esophagus. • GER is common in infants but most grow out of it. • In infants, GER may cause spitting up, vomiting, coughing, poor feed­ ing, or blood in the stools. • Treatment depends on the infant’s symptoms and age and may include changes in eating and sleeping habits. Medication may also be an option. Only rarely and in severe cases is surgery required. Hope Through Research The National Institute of Diabetes and Digestive and Kidney Diseases, through its Division of Digestive Diseases and Nutri­ tion, supports basic and clinical research into gastrointestinal diseases. Researchers are studying the risk factors for developing GER and what causes the LES to open, with the aim of improving future treatment for GER. They are also studying the effica­ cy and safety of drug therapy for the treat­ ment of GER in children and investigating the effectiveness of medications compared with surgery. For More Information North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) P.O. Box 6 Flourtown, PA 19031 Phone: 215–233–0808 Fax: 215–233–3918 Email: [email protected] Internet: www.NASPGHAN.org NASPGHAN’s Children’s Digestive Health and Nutrition Foundation (CDHNF) Internet: www.CDHNF.org www.KidsAcidReflux.org www.TeensAcidReflux.org The U.S. Government does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in this document are used only because they are considered necessary in the context of the information provided. If a product is not mentioned, the omission does not mean or imply that the product is unsatisfactory. 3 Gastroesophageal Reflux in Infants
• 4.
  National Digestive Diseases InformationClearinghouse 2 Information Way Bethesda, MD 20892–3570 Phone: 1–800–891–5389 Fax: 703–738–4929 Email: [email protected] Internet: www.digestive.niddk.nih.gov The National Digestive Diseases Information Clearinghouse (NDDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK is part of the National Institutes of Health under the U.S. Department of Health and Human Services. Established in 1980, the Clearinghouse provides information about digestive diseases to people with digestive disorders and to their families, health care professionals, and the public. The NDDIC answers inquiries, develops and distributes publications, and works closely with professional and patient organizations and Government agencies to coordinate resources about digestive diseases. Publications produced by the Clearinghouse are carefully reviewed by both NIDDK scientists and outside experts. This fact sheet was reviewed by NASPGHAN. This information was prepared in partnership with the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), the Children’s Diges­ tive Health and Nutrition Foundation (CDHNF), and the Association of Pediatric Gastroenterology and Nutri­ tion Nurses (APGNN). The informa­ tion is intended only to provide general information and not as a definitive basis for diagnosis or treatment in any particular case. You should consult your child’s doctor about your child’s specific condition. THE ASSOCIATION OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION NURSES This publication is not copyrighted. The Clearinghouse encourages users of this fact sheet to duplicate and distribute as many copies as desired. This fact sheet is also available at www.digestive.niddk.nih.gov. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health NIH Publication No. 06–5419 August 2006